Transfusion Medicine

Approved nucleic acid testing contributes to safer blood supply

Published in Hepatitis Weekly, April 29th, 2002

The Food and Drug Administration (FDA) has licensed the Chiron Procleix assay for Nucleic Acid Testing (NAT), used by the American Red Cross to detect the genetic material of HIV-1 and hepatitis C virus (HCV) earlier after infection than previously approved serologic tests.

"Our top priority is ensuring a safe and available blood supply for the patients we serve," said Dr. Jerry Squires, vice president and chief scientific officer. "This technique further builds upon today's extremely safe blood supply. NAT is another layer of safety that helps assure patients they receive the safest possible products."

In March 1999, the American Red Cross...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-04-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry